BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 24113229)

  • 1. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Grunebaum E; Cohen A; Roifman CM
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):630-8. PubMed ID: 24113229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enzyme replacement therapy on immune function in ADA deficiency patient.
    Nakazawa Y; Kawai T; Uchiyama T; Goto F; Watanabe N; Maekawa T; Ishiguro A; Okuyama T; Otsu M; Yamada M; Hershfield MS; Ariga T; Onodera M
    Clin Immunol; 2015 Dec; 161(2):391-3. PubMed ID: 26122173
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients.
    Markert ML; Hershfield MS; Schiff RI; Buckley RH
    J Clin Immunol; 1987 Sep; 7(5):389-99. PubMed ID: 3116034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine nucleoside phosphorylase deficiency.
    Markert ML
    Immunodefic Rev; 1991; 3(1):45-81. PubMed ID: 1931007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice.
    Toro A; Grunebaum E
    J Clin Invest; 2006 Oct; 116(10):2717-26. PubMed ID: 16964310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune insufficiency in enzyme defects of purine metabolism].
    Müller G
    Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial Purine Nucleoside Phosphorylase Deficiency Helps Determine Minimal Activity Required for Immune and Neurological Development.
    Grunebaum E; Campbell N; Leon-Ponte M; Xu X; Chapdelaine H
    Front Immunol; 2020; 11():1257. PubMed ID: 32695102
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
    Zegers BJ; Stoop JW
    Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red cell metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy.
    Staal GE; Stoop JW; Zegers BJ; van der Vlist MJ; de Bruyn CH; Wadman SK
    Monogr Hum Genet; 1978; 10():104-7. PubMed ID: 102921
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots.
    la Marca G; Canessa C; Giocaliere E; Romano F; Malvagia S; Funghini S; Moriondo M; Valleriani C; Lippi F; Ombrone D; Della Bona ML; Speckmann C; Borte S; Brodszki N; Gennery AR; Weinacht K; Celmeli F; Pagel J; de Martino M; Guerrini R; Wittkowski H; Santisteban I; Bali P; Ikinciogullari A; Hershfield M; Notarangelo LD; Resti M; Azzari C
    J Allergy Clin Immunol; 2014 Jul; 134(1):155-9. PubMed ID: 24767876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune deficiencies secondary to enzymopathies].
    Pérignon JL; Hamet M
    Ann Pediatr (Paris); 1989 Jun; 36(6):381-5. PubMed ID: 2502942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Shanon A; Levin S; Holtzman F; Brock-Sinai F; Abu-Said A
    Arch Dis Child; 1988 Aug; 63(8):931-4. PubMed ID: 3137899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunodeficiencies associated with errors in purine metabolism.
    Edwards NL
    Med Clin North Am; 1985 May; 69(3):505-18. PubMed ID: 3925260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.
    Giblett ER
    Ciba Found Symp; 1978; (68):3-18. PubMed ID: 115664
    [No Abstract]   [Full Text] [Related]  

  • 18. [Purine nucleoside phosphorylase].
    Pogosian LG; Akopian ZhI
    Biomed Khim; 2013; 59(5):483-97. PubMed ID: 24479338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited disorders of purine metabolism--underlying molecular mechanisms.
    Gutensohn W
    Klin Wochenschr; 1984 Oct; 62(20):953-62. PubMed ID: 6209448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.
    Grunebaum E; Cutz E; Roifman CM
    J Allergy Clin Immunol; 2012 Jun; 129(6):1588-93. PubMed ID: 22409989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.